J&J depression drug Spravato gets half-hearted backing from VA doctors despite...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jun 24, 2019 at 7:32 PM.

  1. #1 cafead, Jun 24, 2019 at 7:32 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via Despite unconventional support from President Donald Trump, Johnson & Johnson’s Spravato didn’t win broad backing at the U.S. Department of Veteran’s Affairs. Agency clinicians instead approved the depression spray’s use on a limited basis, requiring patients to try other options first.

    article source
     
    Quote

Reply to Thread